CARNITOR SF Rx
Generic Name and Formulations:
Levocarnitine 1g/10mL; oral solution; cherry flavor; sugar-free.
Sigma-Tau Pharmaceuticals, Inc.
Indications for CARNITOR SF:
Primary systemic or secondary carnitine deficiency.
Consume slowly in divided doses, preferably with meals; may mix in liquids. Initially 1g/day; titrate slowly; range 1–3g/day.
Consume slowly in divided doses, preferably with meals; may mix in liquids. Initially 50mg/kg per day; titrate slowly; range 50–100mg/kg (max 3g) per day.
Obtain baseline carnitine level; monitor blood chemistry, carnitine levels, vital signs, clinical condition. Seizure disorders. Renal insufficiency (oral forms). Pregnancy (Cat.B). Nursing mothers: not recommended.
Concomitant warfarin: monitor INR.
GI upset/pain, body odor, seizures; inj: hypercalcemia, local reactions.
Tabs—90; Oral soln—4oz; Inj amps or vials (single-dose 5mL)—5
Endocrinology Advisor Articles
- Higher BUN May Increase Risk for Incident Diabetes
- Efficacy of Novel GLP-1 Receptor Agonist Drug Device Examined
- Takeout Food May Increase Adverse Health Consequences in Children
- Nonhormonal Options Available for Menopause Symptom Relief
- Plasma Volume Changes Mediate Risk of CV Mortality With Empagliflozin
- New Consensus Recommendations on Use of Continuous Glucose Monitoring
- Does Genetic Susceptibility Lead to Late-Onset Type 1 Diabetes?
- Clinical Outcomes in T2D: Low-Carbohydrate vs Calorie-Restricted Diet
- New Continuous Glucose Monitoring System Now Available for Medicare Patients
- Text Message-Delivered Interventions Effective for Weight Management
- Effect of Intra-Articular Depot Betamethasone on Insulin Resistance in T2D
- Gastric Bypass vs Sleeve Gastrectomy Outcomes in Morbid Obesity
- Acute Kidney Injury Increases Risk for Postdischarge Hypoglycemia in Diabetes
- Novel Deep Learning System May Help Identify Diabetic Retinopathy
- Trends in CVD, Risk Factors, and Medications in Children With T1D